Work

Corrigendum to “A phase II evaluation of aflibercept in the treatment of recurrent or persistent endometrial cancer: A Gynecologic Oncology Group study” [Gynecol Oncol 127 (2012) 538–543]

Year: 2013

Type: erratum

Source: Gynecologic Oncology

DOI: 10.1016/j.ygyno.2013.04.007

Authors: Robert L. Coleman, Michael W. Sill, Heather A. Lankes, Amanda Nickles Fader, Neil J. Finkler, James S. Hoffman, Peter G. Rose, Gregory P. Sutton, Charles W. Drescher, D. Scott McMeekin, Wei Hu, Michael Deavers, Andrew K. Godwin, R. Katherine Alpaugh, Anil K. Sood

Institutions: The University of Texas MD Anderson Cancer Center, Roswell Park Comprehensive Cancer Center, Walter Reed National Military Medical Center, Florida Hospital Cancer Institute, The Hospital of Central Connecticut, Cleveland Clinic, St Vincent Hospital, University of Oklahoma, University of Kansas Medical Center, Fox Chase Cancer Center

Language: English

Topic: Endometrial and Cervical Cancer Treatments

Subfield: Obstetrics and Gynecology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2071545772

Cites:

Cited by: 4

Related to: 10